Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02664961 |
| Title | Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Tracon Pharmaceuticals Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | child | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Ohio State University | Columbus | Ohio | 43210 | United States | Details | |
| UT Southwestern | Dallas | Texas | 75390 | United States | Details |